Gujarat Themis Biosyn Achieves 52-Week High Amidst Sector Decline and Market Challenges

Gujarat Themis Biosyn, a small-cap player in the Pharmaceuticals & Biotechnology sector, has made headlines today by reaching a new 52-week high of Rs. 404.9. This milestone was achieved on August 1, 2025, marking a significant performance uptick for the company. The stock has outperformed its sector by 3.31% today, reflecting a robust market position amidst broader market challenges.
Over the past two days, Gujarat Themis Biosyn has shown a consecutive gain of 3.61%, indicating a positive trend in its short-term performance. The stock also touched an intraday high of Rs. 404.9, representing a 3.5% increase during the trading session. Notably, it is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting strong momentum.

In contrast, the Pharmaceuticals & Drugs sector has experienced a decline of 2.24%. The broader market, represented by the Sensex, is facing challenges, currently trading at 80,985.66, down 0.25% after opening lower. Over the past year, Gujarat Themis Biosyn has delivered a return of 22.99%, significantly outperforming the Sensex, which has seen a decline of 1.07%. The stock's 52-week low stands at Rs. 192.35, highlighting its substantial recovery.